Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study.
György JermendyZoltán KissGyörgy RokszinZsolt Abonyi-TóthIstván WittmannPéter KemplerPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)
Hungarian Diabetes Association. Plain language summary available for this article.